Timothy B. LowingerPhD
Dr. Lowinger joined Mersana in 2008, where he is responsible for all drug discovery and novel platform discovery efforts. Prior to joining Mersana, Dr. Lowinger held a number of positions at Bayer Pharmaceuticals in the US, Germany, and Japan, where he contributed to the discovery of more than 15 pre-clinical and clinical candidates in the areas of oncology, asthma, urology, virology, diabetes, and Alzheimer’s disease.
Most notably, he led the discovery team and is a co-inventor of the pioneering anti-angiogenic, multi-kinase inhibitor Nexavar, approved for the treatment of kidney, liver and thyroid cancers. Dr. Lowinger earned a B.Sc. (Hons.) in Chemistry and a Ph.D. in Organic Chemistry from the University of British Columbia in Vancouver, Canada, and he was a Merck Postdoctoral Fellow at the Ohio State University in the labs of Professor Leo A. Paquette.